MBRX 8-K: SEC filing
Moleculin Biotech
Filed with the SEC on · accession 0001437749-26-036396
MBRX filed a 8-K (current report) with the SEC on Nov 12, 2026. Moleculin Biotech announced that it was granted Australian Patent No. 2020303572, titled 'Preparation of Preliposomal Annamycin Lyophilizate,' covering the preparation of its drug candidate Annamycin's formulation.
Summary of the filing
Moleculin Biotech announced that it was granted Australian Patent No. 2020303572, titled 'Preparation of Preliposomal Annamycin Lyophilizate,' covering the preparation of its drug candidate Annamycin's formulation. The patent was granted jointly to Moleculin and The Board of Regents of The University of Texas System.
Key details
✦ Ask GOAX AI about this filing — what it means for MBRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MBRX?
Click hereFrequently asked questions
What did MBRX file with the SEC on Nov 12, 2026?
MBRX filed a 8-K (SEC filing). Moleculin Biotech announced that it was granted Australian Patent No. 2020303572, titled 'Preparation of Preliposomal Annamycin Lyophilizate,' covering the preparation of its drug candidate Annamycin's formulation. The patent was granted jointly to Moleculin and The Board of Regents of The University of Texas System.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other MBRX SEC filings
Get alerts when MBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days